Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis

References

• Li P, Znaor A, Holcatova I, et al. Regional geographic variations in kidney cancer incidence rates in European countries. Eur Urol. 2015;67(6):1134–1141. doi:10.1016/j.eururo.2014.11.001
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551
   PubMed Web of Science ®Google Scholar
• Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: renal, Penile, and Testicular Tumours. Eur Urol. 2016;70(1):93–105. doi:10.1016/j.eururo.2016.02.029
   PubMed Web of Science ®Google Scholar
• Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ. 2014;349:g4797. doi:10.1136/bmj.g4797
   PubMed Web of Science ®Google Scholar
• Bellmunt J, Dutcher J. Targeted therapies and the treatment of non-clear cell renal cell carcinoma. Ann Oncol. 2013;24(7):1730–1740. doi:10.1093/annonc/mdt152
   PubMed Web of Science ®Google Scholar
• Feng X, Zhang M, Meng J, et al. Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: a Large-Scale Coexpression Analysis and Clinical Validation. Oncol Res. 2020;28(3):285–297. doi:10.3727/096504020X15791676105394
   PubMed Web of Science ®Google Scholar
• Zhu B, Poeta ML, Costantini M, et al. The genomic and epigenomic evolutionary history of papillary renal cell carcinomas. Nat Commun. 2020;11(1):3096. doi:10.1038/s41467-020-16546-5
   PubMed Web of Science ®Google Scholar
• Yin X, Wang J, Zhang J. Identification of biomarkers of chromophobe renal cell carcinoma by weighted gene co-expression network analysis. Cancer Cell Int. 2018;18:206. doi:10.1186/s12935-018-0703-z
   PubMed Web of Science ®Google Scholar
• Lee WK, Byun SS, Kim HH, et al. Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study. Int J Urol. 2010;17(11):898–904. doi:10.1111/j.1442-2042.2010.02630.x
   PubMed Web of Science ®Google Scholar
• Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23(12):2763–2771. doi:10.1200/JCO.2005.07.055
   PubMed Web of Science ®Google Scholar
• Klatte T, Han KR, Said JW, et al. Pathobiology and prognosis of chromophobe renal cell carcinoma. Urol Oncol. 2008;26(6):604–609. doi:10.1016/j.urolonc.2007.07.015
   PubMed Web of Science ®Google Scholar
• Liu DP, Song H, Xu Y. A common gain of function of p53 cancer mutants in inducing genetic instability. Oncogene. 2010;29(7):949–956. doi:10.1038/onc.2009.376
   PubMed Web of Science ®Google Scholar
• Lin Z, Ren N, Jiang Y, Xu W, Shi Y, Liu G. Adenovirus-Mediated E2F-1 Gene Transfer Augments Gemcitabine-Induced Apoptosis in Human Colon Cancer Cells. Clin Lab. 2015;61(10):1435–1444. doi:10.7754/clin.lab.2015.150104
   PubMed Web of Science ®Google Scholar
• Westendorp B, Mokry M, Groot KM, Holstege FC, Cuppen E, de Bruin A. E2F7 represses a network of oscillating cell cycle genes to control S-phase progression. Nucleic Acids Res. 2012;40(8):3511–3523. doi:10.1093/nar/gkr1203
   PubMed Web of Science ®Google Scholar
• Stevens C, La Thangue NB. E2F and cell cycle control: a double-edged sword. Arch Biochem Biophys. 2003;412(2):157–169. doi:10.1016/s0003-9861(03)00054-7
   PubMed Web of Science ®Google Scholar
• Morgunova E, Yin Y, Jolma A, et al. Structural insights into the DNA-binding specificity of E2F family transcription factors. Nat Commun. 2015;6:10050. doi:10.1038/ncomms10050
   PubMed Web of Science ®Google Scholar
• Manicum T, Ni F, Ye Y, Fan X, Chen BC. Prognostic values of E2F mRNA expression in human gastric cancer. Biosci Rep. 2018;38(6). doi:10.1042/BSR20181264
   PubMed Web of Science ®Google Scholar
• Rennhack J, Andrechek E. Conserved E2F mediated metastasis in mouse models of breast cancer and HER2 positive patients. Oncoscience. 2015;2(10):867–871. doi:10.18632/oncoscience.259
   PubMedGoogle Scholar
• Huang CL, Liu D, Nakano J, et al. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Clin Cancer Res. 2007;13(23):6938–6946. doi:10.1158/1078-0432.CCR-07-1539
   PubMed Web of Science ®Google Scholar
• Kim YS, Jung J, Jeong H, et al. Protein expression profiles and prognostic value of E2F family members in clear cell renal cell carcinoma. Pathol Res Pract. 2020;216(4):152880. doi:10.1016/j.prp.2020.152880
   PubMed Web of Science ®Google Scholar
• Liang B, Zhao J, Wang X. Clinical performance of E2Fs 1–3 in kidney clear cell renal cancer, evidence from bioinformatics analysis. Genes Cancer. 2017;8(5–6):600–607. doi:10.18632/genesandcancer.143
   PubMedGoogle Scholar
• Tomczak K, Czerwinska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19(1A):A68–77. doi:10.5114/wo.2014.47136
   PubMedGoogle Scholar
• Chandrashekar DS, Bashel B, Balasubramanya S, et al. UALCAN: a Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1. doi:10.1126/scisignal.2004088
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Databaseissue):D447–52. doi:10.1093/nar/gku1003
   PubMed Web of Science ®Google Scholar
• Su G, Morris JH, Demchak B, Bader GD. Biological network exploration with Cytoscape 3. Curr Protoc Bioinformatics. 2014;47:1–24. doi:10.1002/0471250953.bi0813s47
   PubMedGoogle Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi:10.1038/s41467-019-09234-6
   PubMed Web of Science ®Google Scholar
• Warde-Farley D, Donaldson SL, Comes O, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38(WebServer issue):W214–20. doi:10.1093/nar/gkq537
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017;77(21):e108–e110. doi:10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Zhu L, Wu W, Jiang S, et al. Pan-Cancer Analysis of the Mitophagy-Related Protein PINK1 as a Biomarker for the Immunological and Prognostic Role. Front Oncol. 2020;10:569887. doi:10.3389/fonc.2020.569887
   PubMed Web of Science ®Google Scholar
• Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200–4202. doi:10.1093/bioinformatics/btz210
   PubMed Web of Science ®Google Scholar
• Liu CJ, Hu FF, Xia MX, Han L, Zhang Q, Guo AY. GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018;34(21):3771–3772. doi:10.1093/bioinformatics/bty411
   PubMed Web of Science ®Google Scholar
• Koch A, Jeschke J, Van Criekinge W, van Engeland M, De Meyer T. MEXPRESS update 2019. Nucleic Acids Res. 2019;47(W1):W561–W565. doi:10.1093/nar/gkz445
   PubMed Web of Science ®Google Scholar
• Azimi F, Scolyer RA, Rumcheva P, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol. 2012;30(21):2678–2683. doi:10.1200/JCO.2011.37.8539
   PubMed Web of Science ®Google Scholar
• Ohtani H. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun. 2007;7:4.
   PubMedGoogle Scholar
• Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet. 2007;8(4):286–298. doi:10.1038/nrg2005
   PubMed Web of Science ®Google Scholar
• Jiang Y, Yim SH, Xu HD, et al. A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma. World J Gastroenterol. 2011;17(4):470–477. doi:10.3748/wjg.v17.i4.470
   PubMed Web of Science ®Google Scholar
• Garneau H, Paquin MC, Carrier JC, Rivard N. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells. J Cell Physiol. 2009;221(2):350–358. doi:10.1002/jcp.21859
   PubMed Web of Science ®Google Scholar
• Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer. 2009;9(11):785–797. doi:10.1038/nrc2696
   PubMed Web of Science ®Google Scholar
• Lu G, Li Y, Ma Y, et al. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res. 2018;37(1):289. doi:10.1186/s13046-018-0945-6
   PubMed Web of Science ®Google Scholar
• Gao Y, Li H, Ma X, et al. KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1. Cancer Res. 2017;77(2):330–342. doi:10.1158/0008-5472.CAN-16-0348
   PubMed Web of Science ®Google Scholar
• Chen L, Yu JH, Lu ZH, Zhang W. E2F2 induction in related to cell proliferation and poor prognosis in non-small cell lung carcinoma. Int J Clin Exp Pathol. 2015;8(9):10545–10554.
   PubMed Web of Science ®Google Scholar
• Yuwanita I, Barnes D, Monterey MD, O’Reilly S, Andrechek ER. Increased metastasis with loss of E2F2 in Myc-driven tumors. Oncotarget. 2015;6(35):38210–38224. doi:10.18632/oncotarget.5690
   PubMedGoogle Scholar
• Li T, Luo W, Liu K, Lv X, Xi T. miR-31 promotes proliferation of colon cancer cells by targeting E2F2. Biotechnol Lett. 2015;37(3):523–532. doi:10.1007/s10529-014-1715-y
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Z, Li Z, et al. MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3. Oncol Rep. 2016;36(3):1293–1300. doi:10.3892/or.2016.4923
   PubMed Web of Science ®Google Scholar
• Sun CC, Li SJ, Hu W, et al. Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer. Mol Ther. 2019;27(6):1153–1165. doi:10.1016/j.ymthe.2019.03.019
   PubMed Web of Science ®Google Scholar
• Olsson AY, Feber A, Edwards S, et al. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene. 2007;26(7):1028–1037. doi:10.1038/sj.onc.1209854
   PubMed Web of Science ®Google Scholar
• Rakha EA, Pinder SE, Paish EC, Robertson JF, Ellis IO. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis. J Pathol. 2004;203(3):754–761. doi:10.1002/path.1573
   PubMed Web of Science ®Google Scholar
• Li SL, Sui Y, Sun J, Jiang TQ, Dong G. Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer. Int J Mol Med. 2018;41(4):2429–2433. doi:10.3892/ijmm.2018.3421
   PubMed Web of Science ®Google Scholar
• Xu H, Fei D, Zong S, Fan Z. MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5. Am J Transl Res. 2016;8(6):2620–2630.
   PubMed Web of Science ®Google Scholar
• Thurlings I, Martinez-Lopez LM, Westendorp B, et al. Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer. Oncogene. 2017;36(6):829–839. doi:10.1038/onc.2016.251
   PubMed Web of Science ®Google Scholar
• Ye L, Guo L, He Z, et al. Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition. Oncotarget. 2016;7(17):23757–23771. doi:10.18632/oncotarget.8121
   PubMedGoogle Scholar
• Kong X, Fu M, Niu X, Jiang H. Comprehensive Analysis of the Expression, Relationship to Immune Infiltration and Prognosis of TIM-1 in Cancer. Front Oncol. 2020;10:1086. doi:10.3389/fonc.2020.01086
   PubMed Web of Science ®Google Scholar
• Xiao Z, Hu L, Yang L, et al. TGFbeta2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer. J Cell Mol Med. 2020;24(13):7151–7162. doi:10.1111/jcmm.15164
   PubMed Web of Science ®Google Scholar
• Liu XS, Gao Y, Liu C, et al. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma. Front Oncol. 2020;10:606735. doi:10.3389/fonc.2020.606735
   PubMed Web of Science ®Google Scholar